SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : NAMX -- North American Expl.-- Que Sera Sera! -- Ignore unavailable to you. Want to Upgrade?


To: Hunter Vann who wrote (2260)1/21/1998 1:01:00 PM
From: MarcG  Read Replies (1) | Respond to of 4736
 
Hunter,
You posted, << But for the record, outstanding shares are those that are actually trading in the public float.>>
This is incorrect. Outstanding shares are the total amount of shares that have been issued by the corporation. This includes but is not limited to
the float as well as shares that are closely held by insiders and/or institutions. The float, those shares that are free to trade in the public market, is usually substantially less than the amount outstanding. As we know from repeated releases, TEIM controls
20.05 M restricted shares of NAMX. If there are 100 M shares out., then this block alone reduces the float to 80 M.
I'm sure insiders control alot of the shares out., so that factor may again reduce the float down to 30-60 M.
All, I'm pleased to see the firm bid on the stock indicating M M willingness to buy higher, sustainable volume levels at 600k, and the new high offer at .225. No matter how many shares are out., the market is beginning to recognize that NAMX has a substantial value.
Wouldn't surprise me to see 1/4 by the close, but it may upset the shorts wagonload.



To: Hunter Vann who wrote (2260)1/21/1998 1:15:00 PM
From: M. M. Jones  Read Replies (1) | Respond to of 4736
 
" As for the Healthcare Field, I've been told Mr. Vann is making quite a bit of money."

Alice, you just keep giving yourself away. Must be a guilty conscience..

With all the gaps in his research and in his factual knowledge, considered alongside his "quite a bit of money", Hunter needs to watch out for a government fraud investigation. Does he have a large Medicare customer base? :-(

M.M.